• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受维持性血液透析的日本患者中,恢复时间与心血管疾病的发病有关。

Recovery time is associated with the onset of cardiovascular disease in Japanese patients undergoing maintenance hemodialysis.

作者信息

Nawano Takaaki, Ichikawa Kazunobu, Konta Tsuneo, Masakane Ikuto, Watanabe Masafumi

机构信息

Department of Cardiology, Pulmonology, and Nephrology, Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Department of Public Health and Hygiene, Yamagata University Graduate School of Medical Science, Yamagata, Japan.

出版信息

Clin Exp Nephrol. 2025 Mar;29(3):342-349. doi: 10.1007/s10157-024-02579-3. Epub 2024 Oct 31.

DOI:10.1007/s10157-024-02579-3
PMID:39477839
Abstract

INTRODUCTION

Cardiovascular disease (CVD) is the leading cause of mortality in patients undergoing maintenance hemodialysis (HD), with various reported risk factors. Recovery time (RT) is a valuable indicator of post-dialysis fatigue. However, the association between RT and the onset of CVD remains unexplored. As such, this study aimed to determine the effect of RT on the onset of CVD.

METHODS

Data from 620 patients undergoing maintenance HD at Yabuki Hospital and 3 related facilities (Yamagata Prefecture, Japan) as of December 31, 2020, were retrospectively analyzed. Patients were asked to respond to the question "How long does it take you to recover from a dialysis session?"; the response was defined as RT. The analysis was performed by categorizing patients into 2 groups according to RT: short RT (< 2 h); and long RT (≥ 2 h). The primary outcome was major adverse cardiovascular events (MACE). Secondary outcomes included all-cause death and hospitalization.

RESULTS

During the 24-month follow-up, 70 (11.3%) patients developed MACE. The long RT group exhibited a higher incidence of MACE; multivariate analysis revealed that age and long RT were associated with the onset of MACE. All-cause death was observed in 45 (7.3%) patients, with no significant difference between the 2 groups. Hospitalization occurred in 252 (40.6%) patients and was more frequent in the long RT group. Multivariate analysis revealed that age, sex, duration of HD, intact parathyroid hormone level, and long RT were associated with hospitalization.

CONCLUSION

Long RT was an independent risk factor for the onset of CVD.

摘要

引言

心血管疾病(CVD)是维持性血液透析(HD)患者的主要死亡原因,有多种已报道的风险因素。恢复时间(RT)是透析后疲劳的一个重要指标。然而,RT与CVD发病之间的关联尚未得到探索。因此,本研究旨在确定RT对CVD发病的影响。

方法

回顾性分析了截至2020年12月31日在日本山形县八木医院及3个相关机构接受维持性HD的620例患者的数据。患者被问及“你从一次透析治疗中恢复需要多长时间?”;该回答被定义为RT。根据RT将患者分为两组进行分析:短恢复时间组(<2小时);长恢复时间组(≥2小时)。主要结局是主要不良心血管事件(MACE)。次要结局包括全因死亡和住院。

结果

在24个月的随访期间,70例(11.3%)患者发生了MACE。长恢复时间组的MACE发生率更高;多因素分析显示年龄和长恢复时间与MACE的发病相关。45例(7.3%)患者发生了全因死亡,两组之间无显著差异。252例(40.6%)患者发生了住院,长恢复时间组更为频繁。多因素分析显示年龄、性别、HD持续时间、完整甲状旁腺激素水平和长恢复时间与住院相关。

结论

长恢复时间是CVD发病的独立危险因素。

相似文献

1
Recovery time is associated with the onset of cardiovascular disease in Japanese patients undergoing maintenance hemodialysis.在接受维持性血液透析的日本患者中,恢复时间与心血管疾病的发病有关。
Clin Exp Nephrol. 2025 Mar;29(3):342-349. doi: 10.1007/s10157-024-02579-3. Epub 2024 Oct 31.
2
The correlation between protein energy wasting and the incidence of main adverse cardiovascular events in adult maintenance hemodialysis patients: a single-center retrospective cohort study.成人维持性血液透析患者蛋白质能量消耗与主要不良心血管事件发生率的相关性:一项单中心回顾性队列研究。
Ren Fail. 2025 Dec;47(1):2441399. doi: 10.1080/0886022X.2024.2441399. Epub 2024 Dec 18.
3
The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study.维持性血液透析患者的心胸比率与全因死亡率和心血管疾病死亡率:MBD - 5D研究结果
Clin Exp Nephrol. 2017 Oct;21(5):797-806. doi: 10.1007/s10157-017-1380-2. Epub 2017 May 15.
4
Association of Nutritional Risk Index With Infection-Related Hospitalization and Death After Hospitalization in Patients Undergoing Maintenance Hemodialysis.营养风险指数与维持性血液透析患者感染相关住院及住院后死亡的关联
J Ren Nutr. 2025 Jan;35(1):187-195. doi: 10.1053/j.jrn.2024.07.017. Epub 2024 Jul 29.
5
Association of plasma macrophage colony-stimulating factor with cardiovascular morbidity and all-cause mortality in chronic hemodialysis patients.血浆巨噬细胞集落刺激因子与慢性血液透析患者心血管发病率和全因死亡率的关系。
BMC Nephrol. 2019 Aug 16;20(1):321. doi: 10.1186/s12882-019-1510-z.
6
Early arteriovenous fistula failure associated with mortality and major adverse cardiovascular events in patients undergoing incident hemodialysis.初次接受血液透析的患者中,早期动静脉内瘘失败与死亡率及主要不良心血管事件相关。
J Vasc Access. 2025 Jan;26(1):175-181. doi: 10.1177/11297298231215106. Epub 2023 Dec 5.
7
Dialysis requirement, long-term major adverse cardiovascular events (MACE) and all-cause mortality in hospital acquired acute kidney injury (AKI): a propensity-matched cohort study.医院获得性急性肾损伤(AKI)的透析需求、长期主要不良心血管事件(MACE)及全因死亡率:一项倾向评分匹配队列研究
J Nephrol. 2016 Dec;29(6):847-855. doi: 10.1007/s40620-016-0321-6. Epub 2016 Jun 15.
8
Body Mass Index Change and Hospitalization Risk in Elderly Hemodialysis Patients: Results from Japanese Dialysis Outcomes and Practice Patterns Study.体重指数变化与老年血液透析患者住院风险:来自日本透析结局和实践模式研究的结果。
Am J Nephrol. 2018;47(1):48-56. doi: 10.1159/000486559. Epub 2018 Jan 24.
9
Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation.血清铁蛋白水平过低和过高均预示着无炎症的血液透析患者的死亡风险。
Clin Exp Nephrol. 2017 Aug;21(4):685-693. doi: 10.1007/s10157-016-1317-1. Epub 2016 Aug 8.
10
Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study.心胸比与血液透析患者全因死亡率和心血管疾病事件:Q 队列研究。
Am J Kidney Dis. 2017 Jul;70(1):84-92. doi: 10.1053/j.ajkd.2016.11.026. Epub 2017 Feb 10.

本文引用的文献

1
Fatigue in Patients Receiving Maintenance Hemodialysis: A Review.维持性血液透析患者的疲劳:综述。
Am J Kidney Dis. 2023 Oct;82(4):464-480. doi: 10.1053/j.ajkd.2023.02.008. Epub 2023 May 13.
2
US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2022年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2023 Mar;81(3 Suppl1):A8-A11. doi: 10.1053/j.ajkd.2022.12.001.
3
Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis.
透析患者肌少症的患病率及其对心血管事件和死亡率的影响:系统评价和荟萃分析。
Nutrients. 2022 Sep 30;14(19):4077. doi: 10.3390/nu14194077.
4
Association of abnormal electrocardiograph metrics with prolonged recovery time in incident hemodialysis patients.异常心电图指标与新进入血液透析患者恢复时间延长的相关性。
BMC Nephrol. 2022 Jan 27;23(1):46. doi: 10.1186/s12882-022-02664-3.
5
Patient-reported outcome measures in hemodialysis patients: results of the first multicenter cross-sectional ePROMs study in France.血液透析患者的患者报告结局测量指标:法国首个多中心横断面 ePROMs 研究结果。
BMC Nephrol. 2021 Oct 30;22(1):357. doi: 10.1186/s12882-021-02551-3.
6
Clinical impact of patient-centered care for hemodialysis patients using routine assessment of symptom burden.常规评估症状负担对血液透析患者实施以患者为中心的护理的临床影响。
Ther Apher Dial. 2022 Apr;26(2):417-424. doi: 10.1111/1744-9987.13704. Epub 2021 Jul 7.
7
Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS.继发性甲状旁腺功能亢进、体重减轻与血液透析患者的长期死亡率:来自 DOPPS 的结果。
J Cachexia Sarcopenia Muscle. 2021 Aug;12(4):855-865. doi: 10.1002/jcsm.12722. Epub 2021 Jun 1.
8
Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment.慢性肾脏病相关性疲劳:流行病学、病理生理学与治疗。
Clin J Am Soc Nephrol. 2021 Sep;16(9):1445-1455. doi: 10.2215/CJN.19891220. Epub 2021 Apr 15.
9
Patient-Reported Outcome Measures in CKD Care: The Importance of Demonstrating Need and Value.慢性肾脏病护理中患者报告的结局指标:证明需求和价值的重要性。
Am J Kidney Dis. 2019 Aug;74(2):148-150. doi: 10.1053/j.ajkd.2019.04.014. Epub 2019 Jun 11.
10
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.实施肾脏病核心结局指标:肾脏病标准化结局研究(SONG)实施研讨会报告。
Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.